EU bars Chinese firms from most medical device tenders
BRUSSELS: The European Union will bar Chinese companies from participating in EU public tenders for medical devices worth €60 billion or more (US$68.90 billion) per year after concluding that EU companies are not given fair access in China.
The measure announced by the European Commission on Friday is the first under the EU's International Procurement Instrument, which entered into force in 2022 and is designed to ensure reciprocal market access.
The new restrictions are likely to increase tensions with Beijing, already inflamed by EU tariffs on China-built electric vehicles, Chinese measures against EU brandy, and curbs on exports of rare earths that the EU wants resolved by an EU-China summit in July.
The Commission said on Friday that it would exclude Chinese companies from EU government purchases above €5 million.
An EU official said, guided by figures from Medtech Europe, the EU medical technology market was worth some €150 billion in 2023, with public procurement accounting for a 70 per cent share. Contracts of over €5 million were only four per cent of tenders, but made up some 60 per cent by value, the official said.
Successful bids will have to ensure they include no more than 50 per cent of medical devices from China. If there are no alternative suppliers, the exclusion will not apply.
EU members backed the plan earlier this month.
The Commission has previously said it found "clear evidence" that China favoured Chinese devices for hospitals and that its tender conditions led to abnormally low bids that profit-oriented companies could not offer.
A Commission official said the ban would cover medical equipment including imaging equipment, artificial body parts and medical clothing.
China's commerce ministry has previously described the proposed EU measures as "protectionist", urging the EU to be fair and transparent and for both sides to resolve differences through cooperation and dialogue.
The Commission said China had not proposed any corrective action to remedy the situation, but an agreement was still possible.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
an hour ago
- The Sun
EU bars China firms from major medical equipment deals
BRUSSELS: The European Union (EU) yesterday banned Chinese firms from government medical device purchases worth more than €5 million (RM25 million) in retaliation for limits Beijing places on access to its own market. The latest salvo in trade tensions between the 27-nation bloc and China covers a wide range of healthcare supplies, from surgical masks to X-ray machines, that represent a market worth €150 billion in the EU. 'Our aim with these measures is to level the playing field for EU businesses,' the bloc's trade commissioner Maros Sefcovic said. 'We remain committed to dialogue with China to resolve these issues.' In response, China accused the EU of 'double standards'. 'The EU has always boasted that it is the most open market in the world, but in reality, it has gradually moved towards protectionism', foreign ministry spokesman Guo Jiakun said at a regular press briefing. 'Under the guise of fair competition (the EU) actually carries out unfair competition, which is a typical case of double standards.' The European Commission said in a statement the move was in 'response to China's longstanding exclusion of EU-made medical devices from Chinese government contracts.' Brussels said just under 90% of public procurement contracts for medical devices in China 'were subject to exclusionary and discriminatory measures' against EU firms. In addition to barring Chinese firms from major state purchases, 'inputs from China for successful bids' would also be limited to 50%, it said. Over the last three years, Brussels and Beijing have come into conflict in a number of economic sectors, including electric cars, the rail industry, solar panels and wind turbines. The decision on medical devices comes at a time of heightened trade tensions with President Donald Trump, which has imposed customs surcharges on imports from all over the world, including Europe. The EU has decided to take a tougher stance on trade in recent years, adopting a vast arsenal of legislation to better defend its businesses against unfair competition. In April 2024, the commission opened an investigation into Chinese public contracts for medical devices, the first under a new mechanism introduced by the EU in 2022 to obtain better access to overseas state purchases. China, on the other hand, accuses Europe of protectionism. After a year of negotiations, the commission, which manages trade policy on behalf of the 27 member states, said it had failed to make any progress with China. 'The measure seeks to incentivise China to cease its discrimination against EU firms and EU-made medical devices and treat EU companies with the same openness as the EU does with Chinese firms and products,' Brussels said. – AFP
The Sun
an hour ago
- The Sun
Derivatives trading boom in India
MUMBAI: Half a dozen global trading giants, from Citadel Securities and IMC Trading to Millennium and Optiver are ratcheting up their presence in India's booming derivatives markets – fuelling a hiring spree and pushing exchanges to improve technology. The firms' hiring plans, being reported for the first time, come amid expectations that large domestic consumer and investor bases will help shield India from global turmoil sparked by the trade policies of US President Donald Trump. The South Asian nation made up nearly 60% of global equity derivative trading volumes of 7.3 billion in April, the Futures Industry Association says, while its regulators say notional turnover of the contracts has grown 48 times since March 2018. For Western firms, the gold rush is too big to ignore, particularly after US trading firm Jane Street earned US$2.34 billion (RM9.9 billion) from its India trading strategy last year, some of the firms' executives said. 'We have seen competition increasing both on the trading front, where you see more players going for the same opportunities, and on the job market as well,' said Jocelyn Dentand of global high-speed trader IMC Trading. The firm plans to grow its team by more than 50% by the end of 2026 to stand at more than 150, added Dentand, the managing director of its India unit. Foreign investors turned buyers of Indian stocks in April and May, purchasing a net US$2.8 billion, as they abandoned their previous selling stance from October 2024 to March 2025, prompted by high valuations and slower growth in earnings. US-based Citadel Securities, a market-making firm founded by well known investor Kenneth Griffin, runs a leaner team of around 10 in India but has ramped up capital allocation to its operations, said a source familiar with its plans. 'In India, we're constantly looking for talent and constantly hiring,' said the source, who sought anonymity in the absence of authorisation to speak to the media and declined to give details of the plan. Hedge fund Millennium is expanding its India desk via Dubai and Singapore, said a source with direct knowledge of the matter, who also sought anonymity on the same grounds. Millennium declined to comment for the story. Citadel Securities did not respond to an email seeking comment. Netherlands-based Optiver, which launched India operations in 2024, plans to grow its team to 100 by the end of 2025, a spokesman said, up from 70 now. 'Optiver is investing ambitiously in India, with a view to expanding to 100 FTEs by year-end and scaling further in the years ahead,' the spokesman added. Amsterdam-based trading firm Da Vinci and London-based Qube Research and Technologies are also recruiting for quantitative trading roles in India, public postings for jobs show. Global trading firms are also looking to expand in India by recruiting aggressively from top domestic universities and poaching from home-grown competitors. They have hired about 300 people in India in the last two years across the trading, technology, compliance, risk, and legal functions, Hong Kong-based recruiter Aquis Search estimates. 'We foresee a good run for the next few years,' said Annpurna Bist, its head of quant and tech. Intensifying competition has driven up salaries, with even junior traders paid more than double the figure of three years ago, said Bhautik Ambani, head of AlphaGrep Investment Management, one of India's leading quant trading firms. India's top engineering schools have become the favoured hunting grounds for talent. 'We almost solely hire our traders and software engineers from Indian Institutes of Technology (IITs),' said IMC's Dentand, referring to the country's chain of prestigious engineering schools. But hiring efforts are now being widened to the universities beyond the IITs, Dentand said. The influx of global trading firms has opened up opportunities for India's two main exchanges, which are both upgrading their tech infrastructure. The National Stock Exchange of India (NSE) plans to add 2,000 co-location racks over the next two years while older stalwart the Bombay Stock Exchange (BSE) aims to scale up to 500 by the end of fiscal 2026, from none in March 2024. Such racks are servers at exchanges that cut trade execution times to microseconds. 'We are a late entrant and need to provide additional value for the unfulfilled demand from high-frequency trading firms and quant firms, amongst others, for co-location racks,' said BSE CEO Sundararaman Ramamurthy. The exchange has spent between 4.5 billion rupees and 5 billion rupees (RM221 million to RM247 million) on technology in the last two years, he said. The NSE and regulator the Securities and Exchange Board of India did not respond to queries for the report. – Reuters
The Star
2 hours ago
- The Star
China condemns British warship's 'troublemaking' Taiwan Strait transit
Britain's Royal Navy said the patrol vessel HMS Spey conducted a routine navigation through the narrow waterway that was part of a long-planned deployment. - UK Ministry of Defence via ST/ANN BEIJING/TAIPEI: China's military on Friday (June 20) condemned the sailing of a British warship through the Taiwan Strait as a deliberate attempt to "cause trouble", as Taiwan's president ordered stepped-up monitoring in response to Chinese military activities. Britain's Royal Navy said the patrol vessel HMS Spey conducted a routine navigation through the narrow waterway that was part of a long-planned deployment and took place in full compliance with international law. China, which views Taiwan as its own territory, considers the strait to be Chinese waters. Taiwan, the United States and many of its allies say it is an international waterway. The Eastern Theatre Command of China's People's Liberation Army said the Wednesday sailing of the ship was "public hyping" and that its forces followed and monitored the Spey. "The British side's remarks distort legal principles and mislead the public; its actions deliberately cause trouble and disrupt things, undermining peace and stability in the Taiwan Strait," it said in a statement. "Troops in the theatre are on high alert at all times and will resolutely counter all threats and provocations." Taiwan's government welcomed the sailing. "The foreign ministry welcomes and affirms the British side once again taking concrete actions to defend the freedom of navigation in the Taiwan Strait, demonstrating its firm position that the Taiwan Strait is international waters," the ministry said in a statement. The last time a British warship sailed through the strait was in 2021, when HMS Richmond was deployed in the East China Sea en route to Vietnam. Chinese military followed it at the time and warned it away. The latest passage comes at a time when Britain and China are seeking to mend their relations, with Prime Minister Keir Starmer expected to visit Beijing later this year - the first trip to the country by a British leader since 2018. US Navy ships sail through the strait around once every two months, sometimes accompanied by allied nations. - Reuters
